Pharmaceutical Manufacturing Deviation and Failure Investigations Principles, Practices, and Case Studies /

This book tackles the crucial topic of deviation and failure investigations in the pharmaceutical industry, recognizing their pivotal influence on regulatory outcomes. Extensive assessments, including analyses of US FDA warning letters and 483 reports, underscore the indispensable necessity of a rob...

Fuld beskrivelse

Saved in:
Bibliografiske detaljer
Main Authors: Pazhayattil, Ajay Babu (Author), Sharma, Sanjay (Author)
Institution som forfatter: SpringerLink (Online service)
Format: Electronisk eBog
Sprog:engelsk
Udgivet: Cham : Springer Nature Switzerland : Imprint: Springer, 2025.
Udgivelse:1st ed. 2025.
Serier:AAPS Introductions in the Pharmaceutical Sciences, 3
Fag:
Online adgang:https://doi.org/10.1007/978-3-031-86504-6
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

MARC

LEADER 00000nam a22000005i 4500
001 978-3-031-86504-6
003 DE-He213
005 20260810114832.0
007 cr nn 008mamaa
008 250320s2025 sz | o |||| 0|eng d
020 |a 9783031865046  |9 978-3-031-86504-6 
024 7 |a 10.1007/978-3-031-86504-6  |2 doi 
050 4 |a RM300-666 
072 7 |a MMG  |2 bicssc 
072 7 |a MED071000  |2 bisacsh 
072 7 |a MKG  |2 thema 
082 0 4 |a 615  |2 23 
100 1 |a Pazhayattil, Ajay Babu.  |e author.  |0 (orcid)0000-0002-9755-8806  |1 https://orcid.org/0000-0002-9755-8806  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
245 1 0 |a Pharmaceutical Manufacturing Deviation and Failure Investigations  |h [electronic resource] :  |b Principles, Practices, and Case Studies /  |c by Ajay Babu Pazhayattil, Sanjay Sharma. 
250 |a 1st ed. 2025. 
264 1 |a Cham :  |b Springer Nature Switzerland :  |b Imprint: Springer,  |c 2025. 
300 |a 1 online resource (XIII, 152 p. 49 illus.).  |b 38 illus. in color. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
341 0 |b Table of contents navigation  |2 onix 
341 0 |b Single logical reading order  |2 onix 
341 0 |b Short alternative textual descriptions  |2 onix 
341 0 |b Use of color is not sole means of conveying information  |2 onix 
341 0 |b Use of high contrast between text and background color  |2 onix 
341 0 |b Next / Previous structural navigation  |2 onix 
341 0 |b All non-decorative content supports reading without sight  |2 onix 
347 |a text file  |b PDF  |2 rda 
490 1 |a AAPS Introductions in the Pharmaceutical Sciences,  |x 2522-8358 ;  |v 3 
505 0 |a Chapter 1: Initial Actions and Information Gathering -- Chapter 2: Root Cause Analysis (RCA) Methods -- Chapter 3: Analytical Tools for Investigation and Generation of Supporting Evidence -- Chapter 4: Management of Deviation and Failure Investigation -- Chapter 5: Post-RCA Impact Assessment, CAPA, and Effectiveness Checks -- Chapter 6: Case Study: Dissolution OOT Observed for an Extended-Release Tablet Formulation -- Chapter 7: Case Study: OOS Uniformity of Dosage Units (Stratified Samples) for a Capsule Formulation -- Appendix I: Non-Conformance/Deviation Investigation -- Appendix II: OOS Failure Investigation -- Appendix III: Review of CDMO Investigation Report. 
520 |a This book tackles the crucial topic of deviation and failure investigations in the pharmaceutical industry, recognizing their pivotal influence on regulatory outcomes. Extensive assessments, including analyses of US FDA warning letters and 483 reports, underscore the indispensable necessity of a robust investigation. The textbook thoroughly explores the standard tools and techniques for conducting scientifically grounded and data-driven investigations. Its overarching objective is to elucidate systematic investigation methodologies that yield effective corrective and preventive actions, ultimately reducing regulatory risks. This book offers a comprehensive overview of standard tools and techniques, focusing on science-based and data-driven approaches. Tailored for professionals in pharmaceutical manufacturing, this book is your go-to resource for mastering investigations in the manufacturing of patient-critical pharmaceutical products. 
532 8 |a Accessibility summary: This PDF does not fully comply with PDF/UA standards, but does feature limited screen reader support, described non-text content (images, graphs), bookmarks for easy navigation and searchable, selectable text. Users of assistive technologies may experience difficulty navigating or interpreting content in this document. We recognize the importance of accessibility, and we welcome queries about accessibility for any of our products. If you have a question or an access need, please get in touch with us at accessibilitysupport@springernature.com. 
532 8 |a No reading system accessibility options actively disabled 
532 8 |a Publisher contact for further accessibility information: accessibilitysupport@springernature.com 
588 |a Print version record. 
650 0 |a Pharmacology. 
650 0 |a Pharmacy. 
650 0 |a Pharmacovigilance. 
650 1 4 |a Pharmacology. 
650 2 4 |a Pharmacy. 
650 2 4 |a Drug Safety and Pharmacovigilance. 
700 1 |a Sharma, Sanjay.  |e author.  |4 aut  |4 http://id.loc.gov/vocabulary/relators/aut 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783031865039 
776 0 8 |i Printed edition:  |z 9783031865053 
776 0 8 |i Printed edition:  |z 9783031865060 
830 0 |a AAPS Introductions in the Pharmaceutical Sciences,  |x 2522-8358 ;  |v 3 
856 4 0 |u https://doi.org/10.1007/978-3-031-86504-6 
912 |a ZDB-2-SBL 
912 |a ZDB-2-SXB 
912 |a ZDB-2-237 
950 |a Biomedical and Life Sciences (SpringerNature-11642) 
950 |a Biomedical and Life Sciences (R0) (SpringerNature-43708) 
950 |a Focus Bundle Biomedical and Human Health Sciences (SpringerNature-85407)